Kessler Investment Group, LLC Amgen Inc Transaction History

Kessler Investment Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	BUY	$255.7 - $288.46 $17,387 - $19,615	68 Added 1.58%	4,383 $1.26 Million
Q3 2023 Oct 18, 2023	BUY	$218.65 - $271.46 $54,225 - $67,322	248 Added 6.1%	4,315 $1.16 Million
Q2 2023 Jul 24, 2023	SELL	$214.27 - $253.37 $89,779 - $106,162	-419 Reduced 9.34%	4,067 $902,000
Q1 2023 Apr 14, 2023	BUY	$225.79 - $275.2 $1.01 Million - $1.23 Million	4,486 New	4,486 $1.08 Million
Q3 2018 Oct 15, 2018	SELL	$185.29 - $208.89 $6,855 - $7,728	-37 Closed	0 $0
Q2 2018 Jul 25, 2018	BUY	$166.05 - $186.51 $6,143 - $6,900	37 New	37 $7,000

3,078

405M

7.56M

7.16M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Kessler Investment Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Kessler Investment Group, LLC with notifications on news.